Not all that glitters is gold

被引：0

作者：

Gazitt, Y ^{[1
]}

机构：

[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA

来源：

BLOOD | 2005年 / 106卷 / 13期

关键词：

D O I：

10.1182/blood-2005-09-3835

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Multiple myeloma (MM) is a difficult disease to treat because of confounding factors such as genetic heterogeneity and the multiplicity and redundancy of survival pathways constitutively activated in this disease.

引用

页码：4025 / 4026

页数：2

共 7 条

[1] Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis [J].

Bharti, AC ;

Shishodia, S ;

Reuben, JM ;

Weber, D ;

Alexanian, R ;

Raj-Vadhan, S ;

Estrov, Z ;

Talpaz, M ;

Aggarwal, BB .

BLOOD, 2004, 103 (08) :3175-3184

[2] Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors [J].

Eskens, FALM ;

Awada, A ;

Cutler, DL ;

de Jonge, MJA ;

Luyten, GPM ;

Faber, MN ;

Statkevich, P ;

Sparreboom, A ;

Verweij, J ;

Hanauske, AR ;

Piccart, M .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :1167-1175

[3] Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma [J].

Hideshima, T ;

Chauhan, D ;

Hayashi, T ;

Akiyama, M ;

Mitsiades, N ;

Mitsiades, C ;

Podar, K ;

Munshi, NC ;

Richardson, PG ;

Anderson, KC .

ONCOGENE, 2003, 22 (52) :8386-8393

[4] 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells [J].

Kulp, SK ;

Yang, YT ;

Hung, CC ;

Chen, KF ;

Lai, JP ;

Tseng, PH ;

Fowble, JW ;

Ward, PJ ;

Chen, CS .

CANCER RESEARCH, 2004, 64 (04) :1444-1451

[5] Clinical update: proteasome inhibitors in hematologic malignancies [J].

Richardson, P .

CANCER TREATMENT REVIEWS, 2003, 29 :33-39

[6] Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-κB activation through inhibition of activation of IκBα kinase and Akt in human non-small cell lung carcinoma:: Correlation with suppression of COX-2 synthesis [J].

Shishodia, S ;

Koul, D ;

Aggarwal, BB .

JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :2011-2022

[7] Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-κB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-κB-regulated gene expression and up-regulation of apoptosis [J].

Takada, Y ;

Khuri, FR ;

Aggarwal, BB .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) :26287-26299

← 1 →